BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 17329575)

  • 1. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.
    Perkins BA; Ficociello LH; Ostrander BE; Silva KH; Weinberg J; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2007 Apr; 18(4):1353-61. PubMed ID: 17329575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.
    Zerbini G; Bonfanti R; Meschi F; Bognetti E; Paesano PL; Gianolli L; Querques M; Maestroni A; Calori G; Del Maschio A; Fazio F; Luzi L; Chiumello G
    Diabetes; 2006 Sep; 55(9):2620-5. PubMed ID: 16936212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
    Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy in children with type 1 diabetes mellitus in Bahrain.
    Al-Hermi BE; Al-Abbasi AM; Rajab MH; Al-Jenaidi FA; Al-Ekri ZE
    Saudi Med J; 2005 Feb; 26(2):294-7. PubMed ID: 15770309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
    Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
    Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
    de Boer IH; Steffes MW
    J Am Soc Nephrol; 2007 Apr; 18(4):1036-7. PubMed ID: 17360946
    [No Abstract]   [Full Text] [Related]  

  • 13. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
    Krolewski AS
    Diabetes Care; 2015 Jun; 38(6):954-62. PubMed ID: 25998286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.
    Rosolowsky ET; Ficociello LH; Maselli NJ; Niewczas MA; Binns AL; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2008 May; 3(3):706-13. PubMed ID: 18272826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New predictive equations improve monitoring of kidney function in patients with diabetes.
    Beauvieux MC; Le Moigne F; Lasseur C; Raffaitin C; Perlemoine C; Barthe N; Chauveau P; Combe C; Gin H; Rigalleau V
    Diabetes Care; 2007 Aug; 30(8):1988-94. PubMed ID: 17536079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M;
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
    Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.